In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8607378 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-4995 (Electronic) Linking ISSN: 0023852X NLM ISO Abbreviation: Laryngoscope Subsets: MEDLINE
    • Publication Information:
      Publication: <2009- >: Philadelphia, PA : Wiley-Blackwell
      Original Publication: St. Louis, Mo. : [s.n., 1896-
    • Subject Terms:
      Optical Imaging*; Carcinoma, Squamous Cell/*pathology ; Folate Receptor 2/*analysis ; Head and Neck Neoplasms/*pathology ; Neoplasm Proteins/*analysis; Adult ; Aged ; Aged, 80 and over ; Animals ; Carcinoma, Squamous Cell/chemistry ; Female ; Folate Receptor 1 ; Head and Neck Neoplasms/chemistry ; Humans ; Mice ; Middle Aged ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck
    • Abstract:
      Objectives/hypothesis: Folate receptor (FR) expression, although known to be elevated in many types of cancer and inflammatory cells, has not been well characterized in head and neck squamous cell carcinoma (HNSCC). We hypothesized that tumor infiltrating inflammatory cells expressing FR-β could allow fluorescent visualization of HNSCC tumors using folate conjugated dyes even when FR expression in cancer cells is low.
      Study Design: Retrospective review of clinical pathologic specimens and in vivo animal study.
      Methods: A tissue microarray with tumor and tumor-free tissue from 22 patients with HNSCC was stained with antibodies to FR-α and FR-β. We characterized FR-β(+) cells by examining CD45, CD68, CD206, and transforming growth factor (TGF)-β expression. To investigate fluorescent imaging, mice with orthotopic tumor xenografts were imaged in vivo after intravenous injections of folate conjugated fluorescein isothiocyanate (folate-FITC) and were histologically evaluated ex vivo.
      Results: All tumor samples demonstrated significant FR-β staining and negligible FR-α staining. FR-β(+) cells found in tumors coexpressed CD68 and had increased expression of CD206 and TGF-β characteristic of tumor-associated macrophages. In the xenograft models, tumors showed strong in vivo fluorescence after folate-FITC injection in contrast to surrounding normal tissues. Histologic examination of the xenograft tissue similarly showed folate-FITC uptake in areas of inflammatory cellular infiltrate.
      Conclusions: Although HNSCC tumor cells do not express FR, HNSCC tumors contain a significant population of FR-β-expressing macrophages. Folate conjugated fluorescent dye is able to specifically target and label tumor xenografts to permit macroscopic fluorescence imaging due to FR-β expression on the infiltrating inflammatory cells.
      (© 2014 The American Laryngological, Rhinological and Otological Society, Inc.)
    • References:
      Cancer Metastasis Rev. 2007 Mar;26(1):141-52. (PMID: 17333345)
      Oncotarget. 2012 Apr;3(4):414-25. (PMID: 22547449)
      Head Neck. 2009 Apr;31(4):475-81. (PMID: 19072997)
      Arch Pathol Lab Med. 2013 Feb;137(2):241-4. (PMID: 22984810)
      Cancer. 1994 May 1;73(9):2432-43. (PMID: 7513252)
      Immunol Rev. 2008 Apr;222:155-61. (PMID: 18364000)
      Semin Oncol. 2011 Feb;38(1):109-18. (PMID: 21362519)
      Anal Biochem. 2005 Mar 15;338(2):284-93. (PMID: 15745749)
      Arthritis Res Ther. 2011 Apr 08;13(2):R59. (PMID: 21477314)
      Head Neck Surg. 1978 Nov-Dec;1(2):107-11. (PMID: 755803)
      Cancer. 1999 Jan 15;85(2):348-57. (PMID: 10023702)
      Br J Oral Maxillofac Surg. 2003 Aug;41(4):224-31. (PMID: 12946663)
      Pancreas. 2013 Jan;42(1):155-9. (PMID: 22699204)
      Bioconjug Chem. 2013 Jun 19;24(6):1075-80. (PMID: 23642154)
      Surgery. 2006 Jun;139(6):839-46. (PMID: 16782443)
      Gynecol Oncol. 2008 Mar;108(3):619-26. (PMID: 18222534)
      Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4317-22. (PMID: 20160097)
      Laryngoscope. 2006 Sep;116(9):1636-41. (PMID: 16954995)
      Arch Otolaryngol Head Neck Surg. 2011 Jun;137(6):609-15. (PMID: 21690514)
      Nature. 2002 Dec 19-26;420(6917):860-7. (PMID: 12490959)
      Int J Cancer. 2008 Oct 1;123(7):1699-703. (PMID: 18646191)
      Ann Surg Oncol. 2012 Nov;19(12):3879-87. (PMID: 22669455)
      J Transl Med. 2011 Dec 16;9:216. (PMID: 22176642)
      Nat Med. 2011 Sep 18;17(10):1315-9. (PMID: 21926976)
      Cancer Res. 2009 Dec 15;69(24):9395-403. (PMID: 19951991)
      N Engl J Med. 2004 May 6;350(19):1945-52. (PMID: 15128894)
      Blood. 2009 Jan 8;113(2):438-46. (PMID: 18952896)
      Ann Surg Oncol. 2012 Jul;19(7):2264-71. (PMID: 22350599)
    • Grant Information:
      Z01 BC010257 United States Intramural NIH HHS; Z01 BC010701 United States Intramural NIH HHS
    • Contributed Indexing:
      Keywords: Head and neck; fluorescence; folate receptor; optical imaging; squamous cell carcinoma; tumor-associated macrophages
    • Accession Number:
      0 (Folate Receptor 1)
      0 (Folate Receptor 2)
      0 (Neoplasm Proteins)
    • Publication Date:
      Date Created: 20140123 Date Completed: 20140919 Latest Revision: 20211021
    • Publication Date:
      20240829
    • Accession Number:
      PMC6980384
    • Accession Number:
      10.1002/lary.24606
    • Accession Number:
      24448885